VALANX Biotech establishes Advisory Board – introducing Pascal Deschatelets
We are happy to introduce and honoured to have Pascal Deschatelets, Co-Founder & Chief Scientific Officer of Apellis Pharmaceuticals, take a seat on and chair our Advisory Board.
Pascal received his PhD degree in organic chemistry from the University of Montreal and his postdoctoral training in the laboratory of Dr. George Whitesides at Harvard University. Before founding Apellis, Pascal co-founded Potentia Pharmaceuticals and was its chief operating officer when the company signed a licensing agreement with Alcon in 2009 for Potentia’s ocular drug development program.
We are looking forward to a bright future with Pascal on-board!
see the corresponding LinkedIn Post